S 1221 ISCommentsClose CommentsPermalink

112th CONGRESSCommentsClose CommentsPermalink

1st SessionCommentsClose CommentsPermalink

S. 1221CommentsClose CommentsPermalink

To provide grants to better understand and reduce gestational diabetes, and for other purposes.CommentsClose CommentsPermalink

IN THE SENATE OF THE UNITED STATESCommentsClose CommentsPermalink

June 16, 2011CommentsClose CommentsPermalink

Mrs. SHAHEEN (for herself and Ms. COLLINS) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and PensionsCommentsClose CommentsPermalink

A BILLCommentsClose CommentsPermalink

To provide grants to better understand and reduce gestational diabetes, and for other purposes.CommentsClose CommentsPermalink

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,CommentsClose CommentsPermalink

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘Gestational Diabetes Act of 2011’ or the ‘GEDI Act’.CommentsClose CommentsPermalink

SEC. 2. GESTATIONAL DIABETES.

Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by adding after section 317H the following:CommentsClose CommentsPermalink

‘SEC. 317H-1. GESTATIONAL DIABETES.

‘(a) Understanding and Monitoring Gestational Diabetes-CommentsClose CommentsPermalink





‘(1) IN GENERAL- The Secretary, acting through the Director of the Centers for Disease Control and Prevention, in consultation with the Diabetes Mellitus Interagency Coordinating Committee established under section 429 and representatives of appropriate national health organizations, shall develop a multisite gestational diabetes research project within the diabetes program of the Centers for Disease Control and Prevention to expand and enhance surveillance data and public health research on gestational diabetes.CommentsClose CommentsPermalink





‘(2) AREAS TO BE ADDRESSED- The research project developed under paragraph (1) shall address--CommentsClose CommentsPermalink





‘(A) procedures to establish accurate and efficient systems for the collection of gestational diabetes data within each State, territory, or possession of the United States;CommentsClose CommentsPermalink





‘(B) the progress of collaborative activities with the National Vital Statistics System, the National Center for Health Statistics, and State health departments with respect to the standard birth certificate, in order to improve surveillance of gestational diabetes;CommentsClose CommentsPermalink





‘(C) postpartum methods of tracking women with gestational diabetes after delivery and targeted interventions proven to lower the incidence of type 2 diabetes in that population;CommentsClose CommentsPermalink





‘(D) variations in the distribution of diagnosed and undiagnosed gestational diabetes, and of impaired fasting glucose tolerance and impaired fasting glucose, within and among groups of women; andCommentsClose CommentsPermalink





‘(E) factors and culturally sensitive interventions that influence risks and reduce the incidence of gestational diabetes and related complications during childbirth, including cultural, behavioral, racial, ethnic, geographic, demographic, socioeconomic, and genetic factors.CommentsClose CommentsPermalink





‘(3) REPORT- Not later than 2 years after the date of the enactment of this section, and annually thereafter, the Secretary shall prepare a report on the findings and recommendations of the research project including prevalence of gestational diabetes in the multisite area and disseminate the report to the appropriate Federal and non-Federal agencies.CommentsClose CommentsPermalink





‘(b) Expansion of Gestational Diabetes Research-CommentsClose CommentsPermalink





‘(1) IN GENERAL- The Secretary shall expand and intensify public health research regarding gestational diabetes. Such research may include--CommentsClose CommentsPermalink





‘(A) developing and testing novel approaches for improving postpartum diabetes testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; andCommentsClose CommentsPermalink





‘(B) conducting public health research to further understanding of the epidemiologic, socioenvironmental, behavioral, translation, and biomedical factors and health systems that influence the risk of gestational diabetes and the development of type 2 diabetes in women with a history of gestational diabetes.CommentsClose CommentsPermalink





‘(2) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this subsection $5,000,000 for each of fiscal years 2012 through 2016.CommentsClose CommentsPermalink





‘(c) Demonstration Grants To Lower the Rate of Gestational Diabetes-CommentsClose CommentsPermalink





‘(1) IN GENERAL- The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award grants, on a competitive basis, to eligible entities for demonstration projects that implement evidence-based interventions to reduce the incidence of gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes.CommentsClose CommentsPermalink





‘(2) PRIORITY- In making grants under this subsection, the Secretary shall give priority to projects focusing on--CommentsClose CommentsPermalink





‘(A) helping women who have 1 or more risk factors for developing gestational diabetes;CommentsClose CommentsPermalink





‘(B) working with women with a history of gestational diabetes during a previous pregnancy;CommentsClose CommentsPermalink





‘(C) providing postpartum care for women with gestational diabetes;CommentsClose CommentsPermalink





‘(D) tracking cases where women with a history of gestational diabetes developed type 2 diabetes;CommentsClose CommentsPermalink





‘(E) educating mothers with a history of gestational diabetes about the increased risk of their children developing diabetes;CommentsClose CommentsPermalink





‘(F) working to prevent gestational diabetes and prevent or delay the development of type 2 diabetes in women with a history of gestational diabetes; andCommentsClose CommentsPermalink





‘(G) achieving outcomes designed to assess the efficacy and cost-effectiveness of interventions that can inform decisions on long-term sustainability, including third-party reimbursement.CommentsClose CommentsPermalink





‘(3) APPLICATION- An eligible entity desiring to receive a grant under this subsection shall submit to the Secretary--CommentsClose CommentsPermalink





‘(A) an application at such time, in such manner, and containing such information as the Secretary may require; andCommentsClose CommentsPermalink





‘(B) a plan to--CommentsClose CommentsPermalink





‘(i) lower the rate of gestational diabetes during pregnancy; orCommentsClose CommentsPermalink





‘(ii) develop methods of tracking women with a history of gestational diabetes and develop effective interventions to lower the incidence of the recurrence of gestational diabetes in subsequent pregnancies and the development of type 2 diabetes.CommentsClose CommentsPermalink





‘(4) USES OF FUNDS- An eligible entity receiving a grant under this subsection shall use the grant funds to carry out demonstration projects described in paragraph (1), including--CommentsClose CommentsPermalink





‘(A) expanding community-based health promotion education, activities, and incentives focused on the prevention of gestational diabetes and development of type 2 diabetes in women with a history of gestational diabetes;CommentsClose CommentsPermalink





‘(B) aiding State- and tribal-based diabetes prevention and control programs to collect, analyze, disseminate, and report surveillance data on women with, and at risk for, gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, and, for women with a history of gestational diabetes, the development of type 2 diabetes; andCommentsClose CommentsPermalink





‘(C) training and encouraging health care providers--CommentsClose CommentsPermalink





‘(i) to promote risk assessment, high-quality care, and self-management for gestational diabetes and the recurrence of gestational diabetes in subsequent pregnancies; andCommentsClose CommentsPermalink





‘(ii) to prevent the development of type 2 diabetes in women with a history of gestational diabetes, and its complications in the practice settings of the health care providers.CommentsClose CommentsPermalink





‘(5) REPORT- Not later than 4 years after the date of the enactment of this section, the Secretary shall prepare and submit to Congress a report concerning the results of the demonstration projects conducted through the grants awarded under this subsection.CommentsClose CommentsPermalink





‘(6) DEFINITION OF ELIGIBLE ENTITY- In this subsection, the term ‘eligible entity’ means a nonprofit organization (such as a nonprofit academic center or community health center) or a State, tribal, or local health agency.CommentsClose CommentsPermalink





‘(7) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this subsection $5,000,000 for each of fiscal years 2012 through 2016.CommentsClose CommentsPermalink





‘(d) Postpartum Follow-Up Regarding Gestational Diabetes- The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall work with the State- and tribal-based diabetes prevention and control programs assisted by the Centers to encourage postpartum follow-up after gestational diabetes, as medically appropriate, for the purpose of reducing the incidence of gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, the development of type 2 diabetes in women with a history of gestational diabetes, and related complications.’.CommentsClose CommentsPermalink